- Home
- BUJA vs ONCY Comparison
BUJA vs ONCY Comparison
Compare BUJA & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BUJA
- ONCY
- Stock Information
- Founded
- BUJA 2022
- ONCY 1998
- Country
- BUJA Malaysia
- ONCY Canada
- Employees
- BUJA N/A
- ONCY N/A
- Industry
- BUJA Blank Checks
- ONCY Pharmaceuticals and Biotechnology
- Sector
- BUJA Finance
- ONCY Health Care
- Exchange
- BUJA Nasdaq
- ONCY Nasdaq
- Market Cap
- BUJA N/A
- ONCY 103.8M
- IPO Year
- BUJA 2023
- ONCY 1999
- Fundamental
- Price
- BUJA $10.96
- ONCY $1.19
- Analyst Decision
- BUJA
- ONCY Strong Buy
- Analyst Count
- BUJA 0
- ONCY 2
- Target Price
- BUJA N/A
- ONCY $4.00
- AVG Volume (30 Days)
- BUJA 2.7K
- ONCY 903.7K
- Earning Date
- BUJA 01-01-0001
- ONCY 11-05-2024
- Dividend Yield
- BUJA N/A
- ONCY N/A
- EPS Growth
- BUJA N/A
- ONCY N/A
- EPS
- BUJA 0.29
- ONCY N/A
- Revenue
- BUJA N/A
- ONCY N/A
- Revenue This Year
- BUJA N/A
- ONCY N/A
- Revenue Next Year
- BUJA N/A
- ONCY N/A
- P/E Ratio
- BUJA $37.13
- ONCY N/A
- Revenue Growth
- BUJA N/A
- ONCY N/A
- 52 Week Low
- BUJA $10.30
- ONCY $0.84
- 52 Week High
- BUJA $12.18
- ONCY $1.80
- Technical
- Relative Strength Index (RSI)
- BUJA 67.66
- ONCY 52.51
- Support Level
- BUJA $10.85
- ONCY $1.17
- Resistance Level
- BUJA $10.85
- ONCY $1.28
- Average True Range (ATR)
- BUJA 0.00
- ONCY 0.09
- MACD
- BUJA -0.00
- ONCY -0.01
- Stochastic Oscillator
- BUJA 87.50
- ONCY 28.00
About BUJA Bukit Jalil Global Acquisition 1 Ltd.
Bukit Jalil Global Acquisition 1 Ltd is a blank check company.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.